Latest debt-to-equity ratio
Kura Oncology Debt-to-equity ratio
Direct answer
Kura Oncology's debt-to-equity ratio is 50.5%.
The verified market snapshot reports 50.5%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Kura Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 50.5%
Explore related company data
View Kura Oncology's market capitalizationView Kura Oncology's price-to-book ratioView Kura Oncology's return on equityView Kura Oncology's dividend yieldView Kura Oncology's 52-week price rangeView Kura Oncology's revenue growthView Kura Oncology's profit marginView all Kura Oncology key metricsReturn to Kura Oncology profile